If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
547.50    0.00 (0.00%)
Bid:
0.00
Ask:
595.00
Spread: 49.00 (8.974%)
Market Cap: £1.48b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Contract Award

19 Apr 2018 07:00

RNS Number : 3744L
Chemring Group PLC
19 April 2018
 

FOR IMMEDIATE RELEASE 19 APRIL 2018

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

 

CONTRACT AWARDS

 

Chemring Group is pleased to announce that the UK Ministry of Defence ("MOD") has now confirmed orders for the next two years totalling approximately £23 million.

 

All contracts are with UK based subsidiaries and are for the supply of countermeasures (£11 million), pyrotechnic products (£8 million) and a range of demolition stores (£4 million).

 

Deliveries under these contracts will be made during the MOD's financial years commencing April 2018 and April 2019.

 

Michael Flowers, Group Chief Executive of Chemring, commented:

 

"We are delighted to receive these awards in support of the UK MOD which further underpin our plans for FY18 and help to build order coverage for FY19.

 

"As the UK MOD seeks to provide the armed forces with the highest level of protection, receipt of these contracts is testament to both the trusted position that Chemring holds with its key domestic customer and the mission-critical nature of our products in protecting the lives of our armed forces.

 

"We look forward to continuing to deliver the highest performing and highest quality products in support of our customers."

 

 

-ENDS-

 

For further information:

 

Rupert Pittman Group Director of Corporate Affairs, 01794 833901

Chemring Group PLC

 

Andrew Jaques MHP Communications 020 3128 8100

James White

 

 

 

 

 

Notes to editors

· Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,600 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under three strategic product segments: Countermeasures, Sensors, and Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk

 

Cautionary statements

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

No statement in this announcement is intended as a profit forecast for FY17 and no statement in this announcement should be interpreted to mean that underlying operating profit for the current or future financial years would necessarily be above a minimum level, or match or exceed the historical published underlying operating profit or set a minimum level of underlying operating profit.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFKFDKPBKDAQD
Date   Source Headline
3rd Feb 201410:37 amRNSHolding(s) in Company
31st Jan 20144:19 pmRNSHolding(s) in Company
30th Jan 20145:10 pmRNSHolding(s) in Company
29th Jan 20145:00 pmRNSHolding(s) in Company
27th Jan 20149:58 amRNSHolding(s) in Company
27th Jan 20147:00 amRNSDisposal
23rd Jan 20147:00 amRNSFinal Results
20th Jan 20142:45 pmRNSHolding(s) in Company
17th Jan 20144:45 pmRNSHolding(s) in Company
16th Jan 201410:14 amRNSHolding(s) in Company
10th Jan 201411:13 amRNSHolding(s) in Company
2nd Jan 20149:57 amRNSTotal Voting Rights
31st Dec 201310:58 amRNSHolding(s) in Company
23rd Dec 20131:57 pmRNSDirectorate Change
23rd Dec 20131:55 pmRNSDirectorate Change
18th Dec 201311:26 amRNSBlocklisting Interim Review
10th Dec 20138:31 amRNSHolding(s) in Company
26th Nov 20133:55 pmRNSHolding(s) in Company
25th Nov 20137:00 amRNSPOST-CLOSE STATEMENT
1st Nov 201310:36 amRNSTotal Voting Rights
18th Oct 20133:19 pmRNSHolding(s) in Company
14th Oct 20132:23 pmRNSHolding(s) in Company
11th Oct 20137:00 amRNSTrading Update
10th Oct 20131:13 pmRNSHolding(s) in Company
1st Oct 201310:06 amRNSTotal Voting Rights
24th Sep 201312:02 pmRNSHolding(s) in Company
17th Sep 20132:10 pmRNSHolding(s) in Company
2nd Sep 201310:11 amRNSTotal Voting Rights
28th Aug 201312:17 pmRNSHolding(s) in Company
28th Aug 20137:00 amRNSInterim Management Statement
19th Aug 20134:36 pmRNSAdditional Listing
31st Jul 20135:08 pmRNSTotal Voting Rights
30th Jul 20133:01 pmRNSDirector/PDMR Shareholding
30th Jul 20132:59 pmRNSDirector/PDMR Shareholding
30th Jul 20132:54 pmRNSDirector/PDMR Shareholding
25th Jul 20139:54 amRNSDirector/PDMR Shareholding
8th Jul 20134:55 pmRNSDocuments Available for Viewing
1st Jul 20138:59 amRNSTotal Voting Rights
25th Jun 20139:34 amRNSDirector/PDMR Shareholding
18th Jun 201311:53 amRNSBlocklisting Interim Review
18th Jun 20137:00 amRNSHalf Yearly Report
4th Jun 20137:00 amRNSAPPOINTMENT OF NON-EXECUTIVE DIRECTOR
3rd Jun 20131:18 pmRNSCONTRACT AWARD
3rd Jun 20139:27 amRNSTotal Voting Rights
1st May 201311:15 amRNSDirectorate Change
1st May 20139:38 amRNSTotal Voting Rights
24th Apr 20137:00 amRNSCONTRACT AWARD
2nd Apr 20139:08 amRNSTotal Voting Rights
28th Mar 20132:05 pmRNSCONTRACT AWARDS
26th Mar 20138:28 amRNSDocuments Available for Viewing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.